Restructuring

BioCryst is closing its discovery labs to save millions, betting on external partnerships for its next big drug. But what is the hidden cost of this pivot?

Michelin's decision to shutter its Tuscaloosa plant isn't just a local tragedy; it's a stark signal of the brutal economics reshaping American manufacturing.

Nanox reports revenue growth but a shrinking cash pile and a stark warning about its future, forcing a strategic retreat from guidance amid legal troubles.

While NANO Nuclear pushes into emerging global markets, a sudden leadership change puts its CEO in direct control of its flagship microreactor project.

After an 80% stock collapse, Dye & Durham replaces its CEO. A new 'Transformation Committee' now steers the ship, tasked with restoring discipline and navigating a critical strategic review.

Airport giant ASUR proposes to bring essential tech services in-house, a strategic pivot balanced by hefty dividends and potential share dilution for investors.

ARS Pharmaceuticals' needle-free allergy spray, neffy, faces a major setback with commercial insurers, forcing a strategic pivot toward fiscal discipline.

In a bold strategic shift, Identiv sells its core IoT business to Trackonomy, transforming into a SaaS firm powered by a major stake in the AI leader.

In a dramatic escalation of an 11-month lockout, Titan Tool & Die has cut benefits for retirees, drawing fierce condemnation from Unifor.

Stegra secures a pivotal €1.4B to build its green steel plant, backed by Sweden's Wallenberg dynasty. This isn't just funding; it's the forging of a new industrial network.

With a novel nasal spray targeting the host, not the virus, RA Capital-backed NorthLinks Bio aims to create a broad-spectrum defense against respiratory threats.

Dubai's Letsia Holding is pivoting from a startup factory to a mature global group. With a new focus on governance and scale, the real test of execution begins.

Hyperscale Data builds a $46M Bitcoin treasury while planning a 590MW AI data center empire, forcing a strategic split and raising investor questions.

The indefinite shutdown of a key Canadian refinery isn't just about one company's troubles; it's a stark warning of North America's fragile EV supply chain.

Largest shareholder Jorey Chernett pressures SMHI's board, alleging operational failures and a valuation disconnect that could be worth billions to investors.

The asset management giant is overhauling its U.S. institutional business, betting that integrated teams and deep consultant ties are the new competitive moats.

ExxonMobil's redomiciliation to Texas is more than a formality. It's a strategic play for legal certainty, solidifying the state's grip on the energy industry.

Brunswick Corp. promises 'multi-million-dollar savings' from operational shifts at its Lowell plant. But behind the corporate buzzwords, a community weighs the price of efficiency.

The government axes its flawed human rights ombudsperson, calling it ineffective. Critics cry abdication, exposing a chasm in corporate oversight.

Small businesses are turning to fast-funding MCAs, only to find themselves in a devastating debt spiral. A look at the hidden risks and paths to recovery.